Impact of prebiotics and probiotics on skin health

Beneficial Microbes

Volumn 5, Issue 2, 2014, Pages 99-107

  Al Ghazzewi, F H ^a   Tester, R F ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Prebiotic; Probiotic; Skin health; Skin microbiota; Synbiotic

Indexed keywords

IMMUNOGLOBULIN E; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

BACTERIAL GROWTH; BACTERIAL VIABILITY; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOREACTIVITY; INNATE IMMUNITY; MICROBIAL COMMUNITY; NONHUMAN; NUTRITIONAL HEALTH; PROTEIN EXPRESSION; REVIEW; SKIN; SKIN CARE; SKIN FLORA; SKIN SURFACE;

PREBIOTIC; PROBIOTIC; SKIN HEALTH; SKIN MICROBIOTA; SYNBIOTIC;

MICROBIOTA; PREBIOTICS; PROBIOTICS; SKIN; SKIN DISEASES; SKIN PHYSIOLOGICAL PHENOMENA;

EID: 84897980427     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.0040     Document Type: Review

References (97)

1. Akiyama, H., Oono, T., Huh, W.K., Yamasaki, O., Akagi, Y., Uemura, H., Yamada, T. and Iwatsuki, K., 2002. Actions of gluco-oligosaccharide against Staphylococcus aureus. Journal of Dermatology 29: 580-586.
2. Al-Ghazzewi, F.H. and Tester, R.F., 2010. Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro. International Journal of Cosmetic Science 32: 139-142.
3. Al-Ghazzewi, F.H., Khanna, S., Tester, R.F. and Piggott, J., 2007. The potential use of hydrolysed konjac glucomannan as a prebiotic. Journal of the Science of Food and Agriculture 87: 1758-1766.
4. Al-Ghazzewi, F.H., Tester, R.F. and Alvani, K., 2012. The synbiotic effects of konjac glucomannan hydrolysates (GMH) and lactobacilli on the growth of Staphylococcus aureus and Salmonella typhimurium. Nutrition and Food Science 42: 97-101.
5. Bastos, M.C., Ceotto, H., Coelho, M.L. and Nascimento, J.S., 2009. Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications. Current Pharmaceutical Biotechnology 10: 38-61.
6. Bateni, E., Tester, R., Al-Ghazzewi, F., Bateni, S. and Piggott, J., 2013. The use of konjac glucomannan hydrolysates (GMH) to improve the health of the skin and reduce acne vulgaris. American Journal of Dermatology and Venereology 2: 10-14.
7. Berardesca, E., Abril, E., Serio, M. and Cameli, N., 2008. Effects of topical gluco-oligosaccharide and collagen tripeptide F in the treatment of sensitive atopic skin. International Journal of Cosmetic Science 31: 271-277.
8. Betsi, G.I., Papadavid, E. and Falagas, M.E., 2008. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomised controlled trials. American Journal of Clinical Dermatology 9: 93-103.
9. Bojar, R.A. and Holland, K.T., 2002. Review: the human cutaneous microflora and factors controlling colonisation. World Journal of Microbiology and Biotechnology 18: 889-903.
10. Bowe, W. and Logan, A.C., 2011, Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future. Gut Pathogens 3: 1-11.
11. Boyle, R.J., Lahtinen, S.J. and Tang, M.L.K., 2011. Probiotics and skin. In: Pappas, A. (ed.) Nutrition and skin: lessons for anti-aging, beauty and healthy skin. Springer Science and Business Media, London, UK, pp. 111-127.
12. Brzuszkiewicz, E., Weiner, J., Wollherr, A., Thürmer, A., Hüpeden, J., Loml, H.B., Daniel, R., Mollenkopf, H-J., Meyer, T.F. and Bruggemann, H., 2011. Comparative genomics and transcriptomics of Propionibacterium acnes. PLoS One 6: e21581.
13. Caramia, G., Atzei, A. and Fanos, V., 2008. Probiotics and the skin. Clinical Dermatology 26: 4-11.
14. Chase, E.P. and Armstrong, A.W., 2012. Advances in management of atopic dermatitis: new therapies and novel uses of existing treatments. Seminars in Cutaneous Medicine and Surgery 31: 17-24.
15. Chiba, Y., Shida, K., Nagata, S., Wada, M., Bian, L., Wang, C., Shimizu, T., Yamashiro, Y., Kiyoshima-Shibata, J., Nanno, M. and Nomoto, K., 2010. Well-controlled proinflammatory cytokine responses of Peyer's patch cells to probiotic Lactobacillus casei. Immunology 130: 352-362.
16. Chon, H., Choi, B., Jeong, G., Lee, E. and Lee, S., 2010. Suppression of proinflammatory cytokine production by specific metabolites of Lactobacillus plantarum 10hk2 inhibiting NF-?B and p38 MAPK expressions. Comparative Immunology, Microbiology and Infectious Diseases 33: e41-e49.
17. Cogen, A.L., Nzet, V. and Gallo, R.L., 2008. Skin microbiota: a source of disease or defence. British Journal of Dermatology 158: 442-455.
18. Cogen, A.L., Yamasaki, K., Sanchez, K.M., Dorschner, R.A., Lai, Y., MacLeod, D.T., Torpey, J.W., Otto, M., Nizet, V., Kim, J.E. and Gallo, R.L., 2010. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. Journal of Investigative Dermatology 130: 192-200.
19. Connolly, M.L., Lovegrove, J.A. and Tuohy, K.M., 2010. Konjac glucomannan hydrolysate beneficially modulates bacterial composition and activity within the faecal microbiota. Journal of Functional Foods 2: 219-224.
20. Costello, E.K., Lauber, C.L., Hamady, M., Fierer, N., Gordon, J.I. and Knight, R., 2009. Bacterial community variation in human body habitats across space and time. Science 326: 1694-1697.
21. Di Marzio, L., Cinque, B., Cupelli, F., De Simone, C., Cifone, M.G. and Giuliani, M., 2008. Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus. International Journal of Immunopathology and Pharmacology 21: 137-143.
22. Eady, E.A. and Ingham, E., 1994. Propionibacterium acnes - friend or foe? Reviews in Medical Microbiology 5: 163-73.
23. Elamir, A.A., Tester, R.F., Al-Ghazzewi, F.H., Kaal, H.Y., Ghalbon, A.A., Elmegrahai, N.A. and Piggott, J.R., 2008. Effects of konjac glucomannan hydrolysates on the gut microflora of mice. Nutrition and Food Science 38: 422-429.
24. Farmer, S. and Mikhail, R., 1998. Topical use of probiotic Bacillus spores to prevent or control microbial infections. Patent, WO9847374.
25. Findley, K., Oh, J., Yang, J. Conlan, S., Deming, C., Meyer, J.A., Schoenfeld, D., Nomicos, E., Park, M., NIH Intramural Sequencing Centre Comparative Sequencing Program; Kong, H.H. and Segre, J.A., 2013. Topographic diversity of fungal and bacterial communities in human skin. Nature 498: 367-370.
26. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2001. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Available at: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.
27. Fooks, L.J. and Gibson, G.R., 2002. Probiotics as modulators of the gut flora. British Journal of Nutrition 88 Suppl. 1: S39-S49.
28. Fredricks, D.N., 2001. Microbial ecology of human skin in health and disease. Journal of Investigative Dermatology Symposium Proceedings 6: 167-169.
29. Fuller, R., 1989. Probiotics in man and animals. Journal of Applied Bacteriology 66: 365-378.
30. Gallo, R., and Nakatsuji, T., 2011. Microbial symbiosis with the innate immune defense system of the skin. Journal of Investigative Dermatology 131: 1974-1980.
31. Gao, Y., Wang, X., Chen, S., Li, S. and Liu, X., 2013. Acute skin barrier disruption with repeated tape stripping: an in vivo model for damage skin barrier. Skin Research and Technology 19: 162-168.
32. Gao, Z., Perez-Perez, G.I., Chen, Y. and Blaser, M.J., 2010. Quantitation of major human cutaneous bacterial and fungal populations. Journal of Clinical Microbiology 48: 3575-3581.
33. Gibson, G.R. and Roberfroid, M.B., 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition 125: 1401-1412.
34. Gribbon, E.M., Cunliffe, W.J. and Holland, K.T., 1993. Interaction of Propionibacterium acnes with skin lipids in vitro. Journal of General Microbiology 139: 1745-1751.
35. Grice, E.A. and Segre, J.A., 2011. The skin microbiome. Nature Reviews Microbiology 9: 244-253.
36. Grice, E.A., Kong, H.H., Conlan, S., Deming, C.B., Davis, J., Young, A.C., NISC Comparative Sequencing Program, Bouffard, G.G., Blakesley, R.W., Murray, P.R., Green, E.D., Turner, M.L. and Segre J.A., 2009. Topographical and temporal diversity of the human skin microbiome. Science 324: 1190-1192.
37. Grice, E.A., Kong, H.H., Renaud, G., Young, A.C., NISC Comparative Sequencing Program, Bouffard, G.G., Blakesley, R.W., Wolfsberg, T.G., Turner, M.L. and Segre, J.A., 2008. A diversity profile of the human skin microbiota. Genome Research 18: 1043-1050.
38. Guéniche, A., Bastien, P., Ovigne, J.M., Kermici, M., Courchay, G., Chevalier, V., Breton, L., and Castiel-Higounenc, I., 2010a. Bifidobacterium longum lysate, a new ingredient for reactive skin. Experimental Dermatology 19: e1-e8.
39. Guéniche, A., Benyacoub, J., Blum, S., Breton, L. and Castiel- Higounenc, I., 2009b. Probiotics for skin benefits. In: Tabor, A. and Blair, R. (eds.) Nutritional cosmetics: beauty from within. Elsevier, Inc., Oxford, UK, pp. 421-439.
40. Guéniche, A., Benyacoub, J., Buetler, T., Smola, H., and Blum, S., 2006a. Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. European Journal of Dermatology 16: 511-517.
41. Guéniche, A., Benyacoub, J., Philippe, D., Bastien, P., Kusy, N., Blum, S., Breton, L. and Castiel-Higounec, I., 2010b. Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. European Journal of Dermatology 20: 731-737.
42. Guéniche, A., Buetler, T., Benyacoub, J., and Blum, S., 2008a. Lactobacillus johnsonii provides a dose-dependent protection against UVR-induced immunosuppression over a large dose range. European Journal of Dermatology 18: 476-477.
43. Guéniche, A., Dahel, K., Bastien, P., Martin, R., Nicolas, J.F. and Breton, L., 2008b. Vitreoscilla filiformis bacterial extract to improve the efficacy of emollient used in atopic dermatitis symptoms. European Academy of Dermatology and Venereology 22: 745-775.
44. Guéniche, A., Hennino, A., Goujon, C., Dahel, K., Bastien, P., Martin, R., Jourdain, R. and Breton, L., 2006b. Improvement of atopic dermatitis skin systems by Vitreoscilla filiformis bacterial extract. European Journal of Dermatology 16: 380-384.
45. Guéniche, A., Knaudt, B., Sckuck, E., Volz, T., Bastien, P., Martin, R., Rocken, M., Breton, L. and Biedermann, T., 2008c. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomised, double-blind, placebo-controlled clinical study. British Journal of Dermatology 159: 1357-1363.
46. Guéniche, A., Philippe, D., Bastien, P., Blum, S., Buyukpamukcu, E. and Castiel-Higounenc, I., 2009a. Probiotics for photoprotection. Dermato-Endocrinology 1: 275-279.
47. Havenaar, R. and Huis in't Veld, J.H.J., 1992. Probiotics: a general view. In: Wood, B.J.B. (ed.) The lactic acid bacteria, Vol. 1. The lactic acid bacteria in health and disease. Chapman and Hall, New York, NY, USA, pp. 209-224.
48. Human Microbiome Project Consortium, 2012. Structure, function and diversity of the healthy human microbiome. Nature 486: 207-214.
49. Kong, H.H. and Segre, J.A., 2012. Skin microbiome: looking back to move forward. Investigative Dermatology 132: 933-939.
50. Kramer, A., Schwebke, I. and Kampf, G., 2006. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infectious Diseases 6: 130.
51. Krutmann, J., 2009. Pre- and probiotics for human skin. Journal of Dermatological Science 54: 1-5.
52. Kwon, H.H., Yoon, J.Y., Park, S.Y. and Suh, D.H., 2013. Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostreptococcus species from acne lesions. British Journal of Dermatology 169: 1152-1155.
53. Levkovich, T., Poutahidis, T., Smillie, C., Varian, B., Ibrahim, Y.M., Lakritz, J.R., Alm, E.J. and Erdman, S.E., 2013. Probiotic bacteria induce a 'glow of health'. PLoS One 8: e53867.
54. Leyden, J.J., McGinley, K.J. and Webster, G.F., 1983. Cutaneous microflora. In: Goldsmith, L.A. (ed.) Biochemistry and physiology of the skin. Oxford University Press, New York, NY, USA, pp. 1153-1165.
55. Leyden, J.J., McGinley, K.J., Nordstrom, K.M. and Webster, G.F., 1987. Skin microflora. Journal of Investigative Dermatology 88: 65S-72S. Meneghin, F., Fabiano, V., Mameli, C. and Zuccotti, G.V., 2012.
56. Meneghin, F., Fabiano, V., Mameli, C. and Zuccotti, G.V., 2012 Probiotics and atopic dermatitis in children. Pharmaceuticals 5: 727-744.
57. Metchnikoff, E., 1907. Lactic acid as inhibiting intestinal putrefaction. In: The prolongation of life: optimistic studies. W. Heinemann, London, UK, pp. 161-183.
58. Murillo, N. and Raoult, D., 2013. Skin microbiota: overview and role in the skin diseases acne vulgaris and rosacea. Future Microbiology 8: 209-222.
59. Nagy, E., Urbán, E., Becker, S., Kostrzewa, M., Vörös, A., Hunyadkürti, J. and Nagy, I., 2013. MALDI-TOF MS fingerprinting facilitates rapid discrimination of phylotypes I, II and III of Propionibacterium acnes. Clinical Microbiology 20: 20-26.
60. Noble, W.C., 1981. Microbiology of human skin. Lloyd-Luke, London, U.K.
61. O'Sullivan, G.C., Kelly, P., O'Halloran, S., Collins, C., Collins, J.K., Dunne, C. and Shanahan, F., 2005. Probiotics: an emerging therapy. Current Pharmaceutical Design 11: 3-10.
62. Oh, J., Conlan, S., Polley, E.C., Segre, J.A. and Kong, H., 2012. Shifts in human skin and nares microbiota of healthy children and adults. Genome Medicine 4: 77.
63. Onishi, N., Kawamoto, S., Nishimura, M., Nakano, T., Aki, T., Shigeta, S., Shimizu, H. Hashimoto, K. and Ono, K., 2005. A new immunomodulatory function of low-viscous konjac glucomannan with a small particle size: its oral intake suppresses spontaneously occurring dermatitis in NC/Nga mice. International Archives of Allergy and Immunology 136: 258-265.
64. Onishi, N., Kawamoto, S., Suzuki, H., Santo, H. Aki, T., Shigeta, S., Hashimoto, K., Hide, M. and Ono, K., 2007a. Dietary pulverised konjac glucomannan suppresses scratching behaviour and skin inflammatory immune responses in NC/Nga mice. International Archives of Allergy and Immunology 144: 95-104.
65. Onishi, N., Kawamoto, S., Ueda, K., Yamanaka, Y., Katayama, A., Suzuki, H., Aki, T., Hashimoto, K., Hide, M. and Ono, K., 2007b. Dietary pulverised konjac glucomannan prevents the development of allergic rhinitis-like symptoms and IgE response in mice. Bioscience, Biotechnology and Biochemistry 71: 2551-2556.
66. Onishi, N., Kunihiko, H. and Hisao, S., 2003. Drug and food containing glucomannan for inhibiting IgE antibody. Patent, EP1283045.
67. Oomizu, S., Onishi, N., Suzuki, H., Ueda, K., Mochizuki, M., Morimoto, K., Kawamoto, S., Ono, K., Kameyoshi, Y. and Hide, M., 2006. Oral administration of pulverised konjac glucomannan prevents the increase of plasma immunoglobulin E and immunoglobulin G levels induced by the injection of syngeneic keratinocyte extracts in BALB/c mice. Clinical and Experimental Allergy 36: 102-110.
68. Ouwehand, A.C., Salminen, S. and Isolauri, E., 2002. Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek 82: 279-289.
69. Paszti-Gere, E., Szeker, K., Csibrik-Nemeth, E., Csizinszky, R., Marosi, A., Palocz, O., Farkas, O. and Galfi, P., 2012. Metabolites of Lactobacillus plantarum 2142 prevent oxidative stress-induced overexpression of proinflammatory cytokines in IPEC-J2 cell line. Inflammation 35: 1487-1499.
70. Peguet-Navarro, J., Dezutter-Dambuyant, C., Buetler, T., Leclaire, J., Smola, H., Blum, S., Bastien, P., Breton, L. and Guéniche, A., 2008. Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized placebo controlled clinical trial. European Journal of Dermatology 18: 504-511.
71. Philippe, D., Guéniche, A., Benyacoub, J. and Blum, S., 2011. Oral Lactobacillus paracasei improves skin barrier function recovery and reduces local skin inflammation. European Journal of Dermatology 21: 279-280.
72. Ritchie, M.L. and Romanuk, T.N., 2012. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7: e34938.
73. Roberfroid, M.B., 2007. Prebiotics: the concept revisited. Journal of Nutrition 137: 830S-837S.
74. Saavedra, J.M. and Tschernia, A., 2002. Human studies with probiotics and prebiotics: clinical implications. British Journal of Nutrition 87 Suppl. 2: S241-S246.
75. Santos, A., San Mauro, M., Sanchez, A., Torres, J.M. and Marquina, D., 2003. The antimicrobial properties of different strains of Lactobacillus spp. isolated from kefir. Systematic and Applied Microbiology 26: 434-437.
76. Schley, P.D. and Field, C.J., 2002. The immune-enhancing effects of dietary fibres and prebiotics. British Journal of Nutrition 87 Suppl. 2: S221-S230.
77. Shu, M., Wang, Y., Yu, J., Kuo, S., Coda, A., Jiang, Y., Gallo, R.L. and Huang, C-M., 2013. Fermentation of Propionibacterium acnes, a commensal bacterium in the human skin microbiome, as skin probiotics against methicillin-resistant Staphylococcus aureus. PLoS One 8: e55380.
78. Su, P., Henriksson, A. and Mitchell, H., 2007. Prebiotics enhance survival and prolong the retention period of specific probiotic inocula in an in vivo murine model. Journal of Applied Microbiology 103: 2392-2400.
79. Sutherland, A., Tester, R., Al-Ghazzewi, F., McCulloch, E. and Connolly, M., 2008. Glucomannan hydrolysate (GMH) inhibition of Candida albicans growth in the presence of Lactobacillus and Lactococcus species. Microbial Ecology in Health and Disease 20: 127-134.
80. Suzuki, H., Oomizu, S., Yanase, Y., Onishi, N., Uchida, K., Mihara, S., Ono, K., Kameyoshi, Y. and Hide, M., 2010. Hydrolysed konjac glucomannan suppresses IgE production in mice B cells. International Archives of Allergy and Immunology 152: 122-130.
81. Swanson, K.S., Grieshop, C.M., Flickinger, E.A., Bauer, L.L., Healy, H.P., Dawson, K.A., Merchen, N.R. and Fahey, G.C. 2002. Supplemental fructooligosaccharides and mannanoligosaccharides influence immune function, ileal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs. Journal of Nutrition 132: 980-989.
82. Tester, R., Al-Ghazzewi, F., Shen, N., Chen, Z., Chen, F., Yang, J., Zhang, D. and Tang, M., 2012. The use of konjac glucomannan hydrolysates (GMH) to recover healthy microflora in infected vaginas treated with antifungal agent. Beneficial Microbes 3: 61-66.
83. Tester, R.F. and Al-Ghazzewi, F.H., 2012. The role of pre- and probiotics in skin care. Inside Cosmeceuticals 1: 5-9.
84. Tester, R.F. and Al-Ghazzewi, F.H., 2013. Mannans and health, with a special focus on glucomannans. Food Research International 50: 384-391.
85. Thormar, H. and Hilmarsson, H., 2007. The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chemistry and Physics of Lipids 150: 1-11.
86. Todoriki, K., Mukai, T., Sato, S. and Toba, T., 2001. Inhibition of adhesion of food-borne pathogens to Caco-2 cells by Lactobacillus strains. Journal of Applied Microbiology 91: 154-159.
87. Tomasik, P.J. and Tomasik, P., 2003. Probiotics and prebiotics. Cereal Chemistry 80: 113-117.
88. Torrecillas, S., Makol, A., Caballero, M.J., Montero, D., Robaina, L., Real, F., Sweetman, J., Tort, L. and Izquierdo M.S., 2007. Immune stimulation and improved infection resistance in European sea bass (Dicentrarchus labrax) fed mannan oligosaccharides. Fish and Shellfish Immunology 23: 969-981.
89. Van Loo, J.V., Cummings, J., Delzenne, N., Englyst, H., Franck, A., Hopkins, M., Kok, N., Macfarlane, G., Newton, D., Quigley, M., Roberfroid, M., Van Vliet, T. and Van den Heuvel, E., 1999. Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRIICT94-1095). British Journal of Nutrition 81: 121-132.
90. Van Reenen, C.A., Dicks, L.M.T. and Chikindas, M.L., 1998. Isolation, purification and partial characterisation of plantaricin 423, a bacteriocin produced by Lactobacillus plantarum. Journal of Applied Microbiology 84: 1131-1137.
91. Verschuere, L., Rombaut, G., Sorgeloos, P. and Verstraete, W., 2000. Probiotic bacteria as biological control agents in aquaculture. Microbiology and Molecular Biology Reviews 64: 655-671.
92. Volz, T. and Biedermann, T., 2009. Outside-in. Probiotic topical agents. Der Hautarzt 60: 795-801.
93. Weston, S., Halbert, A., Richmond, P. and Prescott, S.L., 2005. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Archives of Disease in Childhood 90: 892-897.
94. Yamada, K., Tokunaga, Y., Ikeda, A., Ohkura, K., Kaku-Ohkura, S., Mamiya, S., Lim, B.O. and Tachibana, H., 2003. Effect of dietary fibre on the lipid metabolism and immune function of aged Sprague- Dawley rats. Bioscience, Biotechnology and Biochemistry 67: 429-433.
95. Yesilova, Y., Calka, O., Akdeniz, N. and Berktas, M., 2012. Effect of probiotics on the treatment of children with atopic dermatitis. Annals of Dermatology 24: 189-193.
96. Zeeuwen, P.L.J.M., Boekhorst, J., Van den Bogaard, E.H., De Koning, H.D., Van de Kerkhof, P.M.C., Saulnier, D.M., Van Swam, I.I., Van Hijum, S.A.F.T., Kleerebezem, M., Schalkwijk, J. and Timmerman, H.M., 2012. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biology 13: R101.
97. Zouboulis, C.C, Eady, A., Philpott, M., Goldsmith, L.A., Orfanos, C., Cunliffe, W.C. and Rosenfield, R., 2005. What is the pathogenesis of acne? Experimental Dermatology 14: 143-152.